US 8,999,967 B2Granted

Tricyclic fused ring inhibitors of hepatitis C

AssigneePresidio Pharmaceuticals, Inc.

InventorsLeping Li, Min Zhong

Life of this patent

Estimating the term…

Abstract

Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.

Claims4

Dependent claims

A compound having a formula selected from:

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 13/877,151Filed 28 Sep 2011 · us provisional application
Priority: 29 Sep 2010
Published: US 2013/0296304 A17 Nov 2013
Granted: 7 Apr 2015
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07D 413/14
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms:…
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
A61P 31/14
Antivirals: for RNA viruses
C07D 401/14
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a…:…

Family

Application61/387,974Us provisional application · filed 29 Sep 2010
US 2013/0296304 A1Pre-grant publication · published 7 Nov 2013
US 8,999,967 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results